17-Ethynyl-11-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol

ID: ALA1628161

Chembl Id: CHEMBL1628161

Cas Number: 34816-55-2

PubChem CID: 11954041

Max Phase: Phase

Molecular Formula: C21H26O3

Molecular Weight: 326.44

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Metoxiestrol | R 2858 | R-2858 | Moxestrol|34816-55-2|R 2858|11beta-Methoxyethinylestradiol|METOXIESTROL|CHEBI:34857|R-2858|6923NT44OW|17alpha-Ethinyl-11beta-methoxy-1,3,5(10)-estratrien-3,17-diol|Moxestrolum|(8S,9S,11S,13S,14S,17R)-17-ethynyl-11-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol|Moxestrol [INN:DCF]|Moxestrolum [INN-Latin]|11-beta-Methoxy-17-alpha-ethinylestradiol|UNII-6923NT44OW|CCRIS 7199|RU 2858|BRN 4264994|MOXESTROL [INN]|MOXESTROL Show More

Canonical SMILES:  C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3[C@@H](OC)C[C@@]21C

Standard InChI:  InChI=1S/C21H26O3/c1-4-21(23)10-9-17-16-7-5-13-11-14(22)6-8-15(13)19(16)18(24-3)12-20(17,21)2/h1,6,8,11,16-19,22-23H,5,7,9-10,12H2,2-3H3/t16-,17-,18-,19+,20-,21-/m0/s1

Standard InChI Key:  MTMZZIPTQITGCY-OLGWUGKESA-N

Alternative Forms

  1. Parent:

    ALA1628161

    MOXESTROL

Associated Targets(Human)

SHBG Tchem Testis-specific androgen-binding protein (320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR2 Tclin Estrogen receptor (3070 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ishikawa (877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Esr1 Estrogen receptor (1901 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Afp Alpha-fetoglobulin (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Estrogen receptor (420 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Esr2 Estrogen receptor (2172 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: YesAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 326.44Molecular Weight (Monoisotopic): 326.1882AlogP: 3.24#Rotatable Bonds: 1
Polar Surface Area: 49.69Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.21CX Basic pKa: CX LogP: 3.23CX LogD: 3.23
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.78Np Likeness Score: 1.80

References

1. VanBrocklin HF, Carlson KE, Katzenellenbogen JA, Welch MJ..  (1993)  16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.,  36  (11): [PMID:7684451] [10.1021/jm00063a012]
2. Peters RH, Crowe DF, Avery MA, Chong WK, Tanabe M..  (1989)  17-Desoxy estrogen analogues.,  32  (7): [PMID:2738897] [10.1021/jm00127a040]
3. Christiansen LB, Wenckens M, Bury PS, Gissel B, Hansen BS, Thorpe SM, Jacobsen P, Kanstrup A, Jørgensen AS, Naerum L, Wassermann K..  (2002)  Synthesis and biological evaluation of novel thio-substituted chromanes as high-affinity partial agonists for the estrogen receptor.,  12  (1): [PMID:11738564] [10.1016/s0960-894x(01)00679-5]
4. Jørgensen AS, Jacobsen P, Christiansen LB, Bury PS, Kanstrup A, Thorpe SM, Bain S, Naerum L, Wassermann K..  (2000)  Synthesis and pharmacology of a novel pyrrolo[2,1,5-cd] indolizine (NNC 45-0095), a high affinity non-steroidal agonist for the estrogen receptor.,  10  (4): [PMID:10714509] [10.1016/s0960-894x(00)00015-9]
5. Gantchev TG, Ali H, van Lier JE..  (1994)  Quantitative structure-activity relationships/comparative molecular field analysis (QSAR/CoMFA) for receptor-binding properties of halogenated estradiol derivatives.,  37  (24): [PMID:7990116] [10.1021/jm00050a013]
6. Napolitano E, Fiaschi R, Carlson KE, Katzenellenbogen JA..  (1995)  11 beta-Substituted estradiol derivatives, potential high-affinity carbon-11-labeled probes for the estrogen receptor: a structure-affinity relationship study.,  38  (3): [PMID:7853335] [10.1021/jm00003a005]
7. Ali H, Rousseau J, Ghaffari MA, van Lier JE..  (1991)  Synthesis, receptor binding, and tissue distribution of 7 alpha- and 11 beta-substituted (17 alpha,20E)- and (17 alpha,20Z)-21-[125I]iodo-19-norpregna-1,3,5(10),20-tetraene-3,17-diols.,  34  (2): [PMID:1995909] [10.1021/jm00106a054]
8. Jolivette LJ, Ward KW..  (2005)  Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.,  94  (7): [PMID:15920768] [10.1002/jps.20373]
9. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
10. WHO Anatomical Therapeutic Chemical Classification,